<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04652401</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00997-32</org_study_id>
    <nct_id>NCT04652401</nct_id>
  </id_info>
  <brief_title>Quality of Life in Ventilator-dependant Neuromuscular Patients</brief_title>
  <acronym>EqualVENT</acronym>
  <official_title>Assessment of Quality of Life and Its Determinants in Ventilator-dependent Patients With Slowly Progressive Neuromuscular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Garches</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AFM Téléthon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FilNeMus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating the quality of life of patients with slowly progressive&#xD;
      neuromuscular disorders who are dependant on mechanical ventilation (daily usage ≥ 16h).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Score of the Severe Respiratory Insufficiency questionnaire (SRI)</measure>
    <time_frame>1 Day</time_frame>
    <description>Higher score represents better quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score of the Quality of Life Measure for people with slowly progressive and genetic neuromuscular disease questionnaire (QoL-gNMD)</measure>
    <time_frame>1 Day</time_frame>
    <description>Higher score represents better quality of life</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <condition>Respiration, Artificial</condition>
  <condition>Tracheostomy</condition>
  <condition>Noninvasive Ventilation</condition>
  <condition>Quality of Life</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with slowly progressive neuromuscular disease using home mechanical ventilation&#xD;
        for at least 16 hours a day since at least one year. Patients may be ventilated via&#xD;
        invasive or noninvasive interface.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with slowly progressive neuromuscular disorder (NMD), non walking&#xD;
&#xD;
          -  Patients dependant on mechanical ventilation (daily usage ≥ 16h) for at least 1 year&#xD;
             before inclusion&#xD;
&#xD;
          -  Aged ≥ 18 yo&#xD;
&#xD;
          -  Consent for participation&#xD;
&#xD;
          -  Affiliated to a social security regime&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with medically non-stable NMD: fever, acute respiratory infection, organ&#xD;
             decompensation&#xD;
&#xD;
          -  Patients with significant cognitive impairment (inability to read and/or&#xD;
             incomprehension of questions)&#xD;
&#xD;
          -  Patients with fast-evolving neuromuscular disease&#xD;
&#xD;
          -  Patients declining to participate in the study&#xD;
&#xD;
          -  Patients under guardianship and/or trusteeship&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu Delorme, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederic Lofaso, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Université Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Delorme, MSc</last_name>
    <phone>+33664258007</phone>
    <email>mathieu.delorme.pt@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AFM Téléthon</name>
      <address>
        <city>Évry</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu Delorme, MSc</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

